Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,34 USD | +6,35% | +2,29% | +14,53% |
16/04 | Clearside Biomedical, Inc benoemt Anthony S. Gibney tot lid van de Raad van Bestuur | CI |
18/03 | Clearside Biomedical benoemt Victor Chong tot medisch directeur | MT |
Omzet 2024 * | 2,74 mln. 2,57 mln. | Omzet 2025 * | 7,36 mln. 6,88 mln. | Marktkapitalisatie | 100 mln. 93,64 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -39 mln. -36,48 mln. | Nettowinst (verlies) 2025 * | -43 mln. -40,22 mln. | EV/omzet 2024 * | 28,8 x |
Nettoliquiditeiten 2024 * | 21,26 mln. 19,89 mln. | Nettoschuld 2025 * | 12,33 mln. 11,53 mln. | EV/omzet 2025 * | 15,3 x |
K/w-verhouding 2024 * |
-2,55
x | K/w-verhouding 2025 * |
-2,31
x | Werknemers | 30 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,7% |
Recentste transcriptie over Clearside Biomedical, Inc.
1 dag | +6,35% | ||
1 week | +2,29% | ||
Lopende maand | -12,42% | ||
1 maand | -20,71% | ||
3 maanden | +8,94% | ||
6 maanden | +97,06% | ||
Lopend jaar | +14,53% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 08-08-17 |
Charles Deignan
DFI | Director of Finance/CFO | 59 | 01-01-12 |
Susan L. Coultas
CTO | Chief Tech/Sci/R&D Officer | - | 14-06-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 08-08-17 |
Jeffrey Edwards
BRD | Director/Board Member | 64 | 26-09-18 |
Christy Shaffer
BRD | Director/Board Member | 66 | 01-01-12 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,34 | +6,35% | 154 219 |
25-04-24 | 1,26 | -5,97% | 135 399 |
24-04-24 | 1,34 | -2,19% | 201 427 |
23-04-24 | 1,37 | -2,84% | 232 166 |
22-04-24 | 1,41 | +7,63% | 299 484 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,53% | 100 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |